NCT06093230View on ClinicalTrials.gov

A Study in Subjects With Liver Function Injury and Subjects With Normal Liver Function

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 28, 2023

Primary Completion Date

August 18, 2023

Study Completion Date

August 18, 2023

Conditions
Subjects With Liver Function InjuryNormal Liver Function Subject
Interventions
DRUG

Deuremidevir Hydrobromide Tablets

JT001 single dose, 0.3g

Trial Locations (1)

130021

The First Hospital of Jilin University Ethics Committee, Changchun

All Listed Sponsors
collaborator

Sponsor GmbH

OTHER

lead

Shanghai Vinnerna Biosciences Co., Ltd.

INDUSTRY

NCT06093230 - A Study in Subjects With Liver Function Injury and Subjects With Normal Liver Function | Biotech Hunter | Biotech Hunter